This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 116/8/936    most recent CIRCULATIONAHA.106.677245v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vermeersch, P. Articles by Janssens, S. Search for Related Content PubMed PubMed Citation Articles by Vermeersch, P. Articles by Janssens, S. Pubmed/NCBI databases Gene GEO Profiles HomoloGene Nucleotide Protein UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB NITRIC OXIDE Medline Plus Health Information Pulmonary Hypertension Related Collections Pulmonary circulation and disease Remodeling Genetically altered mice Physiological and pathological control of gene expression Pulmonary biology and circulation

(Circulation. 2007;116:936-943.)
© 2007 American Heart Association, Inc.

Vascular Medicine

Soluble Guanylate Cyclase-1 Deficiency Selectively Inhibits the Pulmonary Vasodilator Response to Nitric Oxide and Increases the Pulmonary Vascular Remodeling Response to Chronic Hypoxia

Pieter Vermeersch, MD^*; Emmanuel Buys, PhD^*; Peter Pokreisz, PhD; Glenn Marsboom, MSc; Fumito Ichinose, MD, PhD; Patrick Sips, MSc; Marijke Pellens, BSc; Hilde Gillijns, BSc; Marc Swinnen, BSc; Amanda Graveline, BSc; Desire Collen, MD, PhD; Mieke Dewerchin, PhD; Peter Brouckaert, MD, PhD; Kenneth D. Bloch, MD; Stefan Janssens, MD, PhD

From the Center for Transgene Technology and Gene Therapy (P.V., P.P., G.M., M.P., H.G., M.S., D.C., M.D., S.J.), VIB, and Department of Cardiology (S.J.), Catholic University of Leuven, Leuven, Belgium; Department of Molecular Biomedical Research (E.B., P.S., P.B.), VIB, Ghent University, Ghent, Belgium; and Cardiovascular Research Center (E.B., F.I., A.G., K.D.B.), Harvard Medical School, Charlestown, Mass.

Correspondence to Stefan Janssens, MD, PhD, Department of Cardiology and Center for Transgene Technology and Gene Therapy, University of Leuven, 49, Herestraat, B-3000 Leuven, Belgium. E-mail stefan.janssens{at}med.kuleuven.be

Received November 22, 2006; accepted June 26, 2007.

Background— Nitric oxide (NO) activates soluble guanylate cyclase (sGC), a heterodimer composed of - and ß-subunits, to produce cGMP. NO reduces pulmonary vascular remodeling, but the role of sGC in vascular responses to acute and chronic hypoxia remains incompletely elucidated. We therefore studied pulmonary vascular responses to acute and chronic hypoxia in wild-type (WT) mice and mice with a nonfunctional 1-subunit (sGC1^–/–).

Methods and Results— sGC1^–/– mice had significantly reduced lung sGC activity and vasodilator-stimulated phosphoprotein phosphorylation. Right ventricular systolic pressure did not differ between genotypes at baseline and increased similarly in WT (22±2 to 34±2 mm Hg) and sGC1^–/– (23±2 to 34±1 mm Hg) mice in response to acute hypoxia. Inhaled NO (40 ppm) blunted the increase in right ventricular systolic pressure in WT mice (22±2 to 24±2 mm Hg, P<0.01 versus hypoxia without NO) but not in sGC1^–/– mice (22±1 to 33±1 mm Hg) and was accompanied by a significant rise in lung cGMP content only in WT mice. In contrast, the NO-donor sodium nitroprusside (1.5 mg/kg) decreased systemic blood pressure similarly in awake WT and sGC1^–/– mice as measured by telemetry (–37±2 versus –42±4 mm Hg). After 3 weeks of hypoxia, the increases in right ventricular systolic pressure, right ventricular hypertrophy, and muscularization of intra-acinar pulmonary vessels were 43%, 135%, and 46% greater, respectively, in sGC1^–/– than in WT mice (P<0.01). Increased remodeling in sGC1^–/– mice was associated with an increased frequency of 5'-bromo-deoxyuridine–positive vessels after 1 and 3 weeks (P<0.01 versus WT).

Conclusions— Deficiency of sGC1 does not alter hypoxic pulmonary vasoconstriction. sGC1 is essential for NO-mediated pulmonary vasodilation and limits chronic hypoxia-induced pulmonary vascular remodeling.

Key Words: guanylate cyclase • nitric oxide • hypoxia • hypertension, pulmonary • remodeling

This article has been cited by other articles:

				E. S. Buys, P. Sips, P. Vermeersch, M. J. Raher, E. Rogge, F. Ichinose, M. Dewerchin, K. D. Bloch, S. Janssens, and P. Brouckaert Gender-specific hypertension and responsiveness to nitric oxide in sGC{alpha}1 knockout mice Cardiovasc Res, April 3, 2008; (2008) cvn068v2. [Abstract] [Full Text] [PDF]

				P. J. McNamara, P. Murthy, C. Kantores, L. Teixeira, D. Engelberts, T. van Vliet, B. P. Kavanagh, and R. P. Jankov Acute vasodilator effects of Rho-kinase inhibitors in neonatal rats with pulmonary hypertension unresponsive to nitric oxide Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L205 - L213. [Abstract] [Full Text] [PDF]